Overview: Reticulocyte Count TestIntroduction: The Reticulocyte Count Test measures reticulocytes to diagnose anemia or bone marrow disorders, causing fatigue. Following 2023 ASH guidelines, it uses hematological methods for high specificity, supporting blood disorder screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in hematology for patients with suspected anemia or bone marrow dysfunction.
Other Names: Reticulocyte Assay, Immature RBC Count Test.
FDA Status: Laboratory-developed test (LDT), meeting hematology standards for diagnostic accuracy.
Historical Milestone: Reticulocyte counting began in the 1940s with anemia research. Automated methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures reticulocytes to diagnose anemia or bone marrow disorders, guides treatment, and evaluates patients with fatigue.
Test Parameters: 1. Reticulocyte Count
Pretest Condition: No fasting required. Collect whole blood. Report history of fatigue or bone marrow disorder symptoms.
Specimen: Whole Blood (EDTA, 2-5 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fatigue, anemia, or history of bone marrow disorders. Include current medications, especially erythropoietin.
Consent: Written consent required, detailing the tests purpose, anemia/bone marrow disorder implications, and risks of sample collection.
Procedural Considerations: Uses flow cytometry or microscopy to measure reticulocyte count. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for anemia diagnosis.
Factors Affecting Result Accuracy: Improper sample storage or hemolysis can affect results. Recent transfusions may alter reticulocyte count.
Clinical Significance: Low reticulocyte count confirms bone marrow suppression, guiding erythropoietin therapy. High count suggests hemolytic anemia, requiring further testing.
Specialist Consultation: Consult a hematologist for result interpretation and treatment planning.
Additional Supporting Tests: Bone marrow biopsy, hemoglobin, or iron studies to confirm anemia/bone marrow disorder diagnosis.
Test Limitations: Non-specific for certain anemia causes; clinical correlation is needed. Sample quality affects sensitivity.
References: ASH Anemia Guidelines, 2023; Blood, Hillman RS, 2022.
